Priority Date: 10.08.12 (JP 20120177631)

ANTIGEN PEPTIDE ORIGINATED FROM T790M POINT-MUTATED SEQUENCE OF EPIDERMAL GROWTH FACTOR RECEPTOR

  • Application ID: EP13827804
  • Status: GRANT OF PATENT INTENDED

Attorney

Employment test 51 - 200 employees
Company dna vossius and partner
operating since 1961
Headquarter in Munich and 3 offices
active in Legal Services and IP-related Communication Service

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Vossius & Partner Patentanwälte Rechtsanwälte mbB is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB, Isenbruck Bösl Hörschler LLP and 185 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 10.08.2012 - Priority Date (JP 20120177631)
  • 13.02.2014 - Publication A1 (WO2014024965)
  • 17.06.2015 - Publication A1 (EP2883884)